Search Results for keywords:"grant applications"

The Center for Scientific Review from the National Institutes of Health announced several meetings that will be closed to the public. These meetings, scheduled for various dates in February 2025, will review and evaluate grant applications in fields such as brain disorders, pulmonary diseases, and genetics. The discussions are confidential as they might reveal trade secrets, patentable materials, or personal information. All meetings will be conducted virtually, and contact details for the respective Scientific Review Officers are provided for each committee.

The National Institutes of Health (NIH) has announced that multiple advisory committee meetings will be held regarding the review and evaluation of grant applications. All meetings will be conducted virtually and are closed to the public to protect confidential information and personal privacy. These meetings include various specialized groups focusing on topics such as cancer therapeutics, bioengineering, and population sciences. The meetings occur in March and April 2025, with detailed information available for each session, such as committee names, dates, times, agenda points, and contact persons.

The Department of Education is inviting public comments regarding the reinstatement of a data collection activity without changes under the Paperwork Reduction Act of 1995. This collection concerns applications for grants under the Historically Black Colleges and Universities Master's Degree Program, which aims to improve educational opportunities at the master's level for African Americans in specific fields like science and technology. Comments should be submitted by March 1, 2021, and the program offers grants for up to six years to qualified institutions that significantly contribute to graduate education for African Americans. The Department is interested in public opinions on the necessity, usefulness, and potential burden of this data collection effort.

The National Institute of Allergy and Infectious Diseases (NIAID) is holding a closed meeting on April 24, 2025, to review grant applications related to inducing HIV immunity in early life. This meeting will take place at the NIAID's facility in Rockville, Maryland, and will be conducted via video assistance. The discussions will cover confidential trade secrets and personal information, which is why the meeting is not open to the public. The meeting is organized under the guidelines of the Federal Advisory Committee Act.

The Center for Scientific Review announced several closed meetings to evaluate grant applications for scientific research. These meetings are scheduled to take place virtually at the National Institutes of Health on specific dates in February 2025 and will be restricted to the public to protect confidential information and personal privacy. Various committees focusing on fields such as cardiovascular science, bioengineering, oncology, biobehavioral processes, social psychology, and endocrinology will hold these sessions. Scientific Review Officers are designated for each committee to manage the proceedings and can be contacted for further information.

The National Institute on Aging is holding a meeting focused on evaluating grant applications for a clinical trial involving older individuals. This meeting, scheduled for February 26, 2021, from 11:00 a.m. to 5:00 p.m., will be closed to the public due to the potential disclosure of confidential information such as trade secrets and personal data. The meeting will take place via video at the Gateway Building in Bethesda, Maryland, and will be led by Dr. Maurizio Grimaldi, a Scientific Review Officer.

In accordance with the Federal Advisory Committee Act, the National Institutes of Health (NIH) announced that several meetings of the Center for Scientific Review will be held virtually. These meetings, taking place between March 19 and March 24, 2021, are closed to the public due to the sensitive nature of the discussions, which include evaluating grant applications and potential disclosure of confidential materials. The subject matter of the meetings ranges from drug discovery and neurodegenerative disorders to HIV/AIDS prevention and treatment, with various scientific review officers assigned to manage the sessions. These sessions aim to review and evaluate various grant proposals, ensuring that personal privacy and proprietary information remain protected.

The National Institutes of Health (NIH) has announced a closed meeting for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Special Emphasis Panel on February 10, 2021. This meeting will involve reviewing and evaluating grant applications. It is closed to the public to protect sensitive information such as personal privacy and confidential business information. The meeting will be conducted via video conference, and further inquiries can be directed to Dr. Xiaodu Guo, the Scientific Review Officer.

The National Institute of Neurological Disorders and Stroke (NINDS) has announced a series of closed meetings as outlined in sections of the Federal Advisory Committee Act. These meetings, occurring from February 12 to March 2, 2021, will review and evaluate grant applications related to neurological disorders. Attendees of the meetings include various scientific review officers and other participants, with all meetings taking place virtually due to their confidential nature. The discussions are closed to the public to protect sensitive information such as trade secrets and personal data.

The National Institutes of Health (NIH) and the Department of Health and Human Services have announced a series of closed meetings conducted under the Federal Advisory Committee Act. These meetings, scheduled for March 11-12, 2021, are organized by various review panels under the Center for Scientific Review. They aim to review and evaluate different grant applications. Topics include clinical neurophysiology, immuno-oncology, computational modeling, infectious diseases, and more. The discussions are confidential due to potential disclosure of trade secrets and personal information.